Chemistry:Sulforidazine

From HandWiki

Sulforidazine (Imagotan, Psychoson, Inofal) a typical antipsychotic and a metabolite of thioridazine; it and mesoridazine are more potent than the parent compound, whose pharmacological effects are believed by some to be largely due to its metabolism into sulforidazine and mesoridazine.[1]

Synthesis

Synthesis of sulforidazine

Sulforidazine can be synthesized starting 2-bromo-2'-amino-4'-methylsulfonyl-diphenyl sulfide (1).[2][3][4] Acetylation produces 2-bromo-2'-acetamino-4'-methylsulphonyl diphenylsulfide (2), which is then alkylated with 2-(2-chloroethyl)-1-methylpiperidine (3). Deacylation followed by a copper-catalyzed ring-formation reaction produces sulforidazine.

References

  1. "Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors". The Journal of Pharmacology and Experimental Therapeutics 228 (3): 636–639. March 1984. doi:10.1016/S0022-3565(25)21884-5. PMID 6707914. 
  2. "Sulforidazine". Thieme Pharmaceutical Substances. https://pharmaceutical-substances.thieme.com/lexicon/KD-19-0102?searchterm=sulforidazine&context=search. 
  3. "Facile Syntheses of the Three Major Metabolites of Thioridazine". Helvetica Chimica Acta 88 (5): 962–967. 2005. doi:10.1002/hlca.200590089. Bibcode2005HChAc..88..962M. 
  4. Bruschweiler C, Schwarb G, Winkler H, Renz J, "Heterocyclic compounds", US patent 3314948, issued 18 April 1967.